The Broad Institute Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of The Broad Institute Inc. opposed by its competitors

Patent:
Grant Date:
Sep 18, 2024
Title:
Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin Reinduction
Oppositions:
1
Patent:
Grant Date:
Jul 26, 2023
Title:
Crispr Having Or Associated With Destabilization Domains
Oppositions:
2
Patent:
Grant Date:
Oct 28, 2020
Title:
Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
Oppositions:
5
Patent:
Grant Date:
Sep 30, 2020
Title:
Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
Oppositions:
2
Patent:
Grant Date:
May 27, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
4
Patent:
Grant Date:
Feb 12, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
4
Patent:
Grant Date:
Feb 12, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
4
Patent:
Grant Date:
Oct 16, 2019
Title:
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells
Oppositions:
2
Patent:
Grant Date:
Mar 7, 2018
Title:
Crispr-Related Methods And Compositions With Governing Grnas
Oppositions:
2

Want to track The Broad Institute Inc.?

Feel free to send us a message here and we will get back to you